Intrinsic Value

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Panacea Biotec Consolidated March 2022 Net Sales at Rs 140.73 crore, down 16.37% Y-o-Y

Panacea Biotec reports consolidated net profit of Rs 1237.42 crore in the March 2022 quarter

Panacea Biotec reports standalone net loss of Rs 25.31 crore in the March 2022 quarter

As a result, PBPL has now become a debt free company.

Panacea Biotec Pharma redeems entire outstanding NCDs

Panacea Biotec shares touched an intra day high of Rs 198.5 , up 5% on BSE. Market cap of the firm rose to Rs 1209.70 crore.

Panacea Biotec shares hit upper circuit in early trade, here’s why

Stocks In the News: Check out the companies making headlines before the opening bell

Buzzing Stocks | Vedant Fashions, Panacea Biotec, DB Realty, others in news today

As part of the arrangement, Mankind Pharma Ltd, has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business.

Mankind Pharma acquires Panacea’s domestic formulation brands for Rs 1,872 cr

Panacea Biotec Pharma sells its pharmaceutical formulation brands in India and Nepal

Panacea Biotec and its wholly-owned subsidiary Panacea Biotec Pharma (PBPL) have entered into definitive agreements for sale of pharmaceutical formulations brands of PBPL for India and Nepal, to Mankind Pharma.

Mankind Pharma acquires Panacea Biotec’s domestic formulation brands for India and Nepal

Both the entities have entered into definitive agreements for the transaction involving a total consideration of Rs 1,872 crore. Panacea Biotec Pharma Ltd is a wholly-owned subsidiary of Panacea Biotec.

Mankind Pharma to acquire Panacea’s formulation brands for India, Nepal

Check out the stocks that will be in focus during trade today based on recent and latest news developments.

Top stocks in focus: Apollo Hospitals, Bharat Electronics, Panacea Biotec, Hinduja Global, JSW ISPAT

Panacea Biotec Limited is a health management company. The Company's principal business activity is the manufacture of allopathic pharmaceuticals preparations.

Panacea Biotec Ltd

Panacea Biotec Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Panacea Biotec Consolidated March 2022 Net Sales at Rs 140.73 crore, down 16.37% Y-o-Y

Panacea Biotec reports consolidated net profit of Rs 1237.42 crore in the March 2022 quarter

Panacea Biotec reports standalone net loss of Rs 25.31 crore in the March 2022 quarter

Panacea Biotec Pharma redeems entire outstanding NCDs

Panacea Biotec shares hit upper circuit in early trade, here’s why

Buzzing Stocks | Vedant Fashions, Panacea Biotec, DB Realty, others in news today

Mankind Pharma acquires Panacea’s domestic formulation brands for Rs 1,872 cr

Panacea Biotec Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Panacea Biotec Consolidated March 2022 Net Sales at Rs 140.73 crore, down 16.37% Y-o-Y

Panacea Biotec reports consolidated net profit of Rs 1237.42 crore in the March 2022 quarter

Panacea Biotec reports standalone net loss of Rs 25.31 crore in the March 2022 quarter

Panacea Biotec Pharma redeems entire outstanding NCDs

Panacea Biotec shares hit upper circuit in early trade, here’s why

Buzzing Stocks | Vedant Fashions, Panacea Biotec, DB Realty, others in news today

Mankind Pharma acquires Panacea’s domestic formulation brands for Rs 1,872 cr

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock